Ginkgo Bioworks Holdings, Inc. (DNA)

USD 7.04

(1.15%)

Net Income Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual net income in 2023 was -892.86 Million USD , up 57.58% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly net income in 2024 Q1 was -165.91 Million USD , up 21.63% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported an annual net income of -2.1 Billion USD in 2022, down -15.02% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported an annual net income of -1.83 Billion USD in 2021, down -1345.43% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly net income of -217.18 Million USD for 2024 Q2, down -30.9% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly net income of -302.89 Million USD for 2023 Q3, down -74.76% from previous quarter.

Annual Net Income Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Net Income of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Net Income Net Income Growth
2023 -892.86 Million USD 57.58%
2022 -2.1 Billion USD -15.02%
2021 -1.83 Billion USD -1345.43%
2020 -126.6 Million USD -6.1%
2019 -119.32 Million USD 0.0%
2001 - USD 0.0%

Peer Net Income Comparison of Ginkgo Bioworks Holdings, Inc.

Name Net Income Net Income Difference
ADC Therapeutics SA -240.05 Million USD -271.947%
Alto Neuroscience, Inc. -36.3 Million USD -2359.355%
Annovis Bio, Inc. -56.2 Million USD -1488.613%
Biohaven Pharmaceutical Holding Company Ltd. -408.16 Million USD -118.75%
Nuvation Bio Inc. -75.8 Million USD -1077.896%
Nuvation Bio Inc. -75.8 Million USD -1077.896%
Arcus Biosciences, Inc. -307 Million USD -190.837%
Zymeworks Inc. -118.67 Million USD -652.371%